Nonlinear association and threshold effect between preoperative estimated pulse wave velocity and postoperative atrial fibrillation after coronary artery bypass grafting

冠状动脉旁路移植术后,术前估计脉搏波速度与术后房颤之间的非线性关联和阈值效应

阅读:2

Abstract

BACKGROUND: Postoperative atrial fibrillation (POAF) is a common complication after coronary artery bypass grafting (CABG), yet reliable preoperative risk markers remain limited. Estimated pulse wave velocity (ePWV), a simple noninvasive indicator of arterial stiffness, may enhance risk stratification; however, its association with POAF has not been fully elucidated. This study aimed to investigate the nonlinear association and potential threshold effect between preoperative ePWV and POAF in patients undergoing CABG. METHODS: This single-center retrospective cohort study included 8,570 patients who underwent CABG between 2021 and 2022 at Beijing Anzhen Hospital. ePWV was calculated using age and mean blood pressure. Logistic regression, restricted cubic spline (RCS) modeling, and two-piecewise linear regression were used to evaluate the association and potential threshold effect between ePWV and POAF. Predictive performance was evaluated using receiver operating characteristic (ROC) analysis. RESULTS: POAF occurred in 7.9% of patients. Higher ePWV was independently associated with POAF [adjusted odds ratio (OR): 1.15, 95% confidence interval (CI): 1.09-1.21; P<0.001]. A significant nonlinear relationship was observed, with an inflection point at 11.4 m/s. Below this threshold, each 1 m/s increase in ePWV was associated with a 27% higher risk of POAF, whereas no significant association was observed at ePWV values ≥11.4 m/s. The area under the curve (AUC) for ePWV was 0.583, and the optimal cutoff of 9.62 meters per second yielded a negative predictive value of 94.6%. CONCLUSIONS: ePWV shows an independent and nonlinear association with POAF after CABG, with identifiable thresholds that may inform preoperative risk stratification. As a simple and noninvasive measure of arterial stiffness, ePWV may assist in identifying patients at elevated risk of POAF. Validation in multicenter prospective cohorts is warranted to establish its broader clinical utility.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。